Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug safety check: how does anaprazole affect liver, kidney, and elderly patients?

NCT ID NCT07345689

First seen Jan 18, 2026 · Last updated Jun 18, 2026 · Updated 20 times

Summary

This study looks at how the drug anaprazole sodium is processed by the body and whether it is safe for people with liver or kidney issues, as well as for older adults. About 60 participants will be enrolled to measure drug levels and track any side effects. The goal is to understand how these special populations handle the drug compared to healthy individuals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELDERLY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

Hepatic Insufficiency kidney failure liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.